Aspicio Therapeutics, Inc.

CIK 2025735 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Aspicio Therapeutics, Inc..

Recent SEC filings

FiledFormAccession number
Jul 17, 2026D0002025735-26-000001
Jun 21, 2024D0002025735-24-000001